Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(4 sites)

United States

Bausch Health Site 008, Garden Grove, California

Bausch Health Site 003, Indianapolis, Indiana

Bausch Health Site 006, The Bronx, New York

Bausch Health Site 010, Greenville, North Carolina